Bluebird Bio Performance
| BLUEDelisted Stock | USD 4.97 0.23 4.85% |
The firm shows a Beta (market volatility) of 2.04, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bluebird Bio will likely underperform. Bluebird Bio right now shows a risk of 0.0%. Please confirm Bluebird Bio maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to decide if Bluebird Bio will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bluebird Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bluebird Bio is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Bluebird |
Bluebird Bio Relative Risk vs. Return Landscape
If you would invest 497.00 in Bluebird Bio on October 1, 2025 and sell it today you would earn a total of 0.00 from holding Bluebird Bio or generate 0.0% return on investment over 90 days. Bluebird Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Bluebird, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bluebird Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bluebird Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bluebird Bio, and traders can use it to determine the average amount a Bluebird Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BLUE |
Based on monthly moving average Bluebird Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bluebird Bio by adding Bluebird Bio to a well-diversified portfolio.
Bluebird Bio Fundamentals Growth
Bluebird Stock prices reflect investors' perceptions of the future prospects and financial health of Bluebird Bio, and Bluebird Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bluebird Stock performance.
| Return On Equity | -5.47 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.92) % | |||
| Operating Margin | (0.56) % | |||
| Current Valuation | 158.07 M | |||
| Shares Outstanding | 9.79 M | |||
| Price To Earning | (19.32) X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 83.81 M | |||
| EBITDA | (156.82 M) | |||
| Cash And Equivalents | 132.51 M | |||
| Cash Per Share | 1.72 X | |||
| Total Debt | 358.24 M | |||
| Debt To Equity | 1.63 % | |||
| Book Value Per Share | (5.91) X | |||
| Cash Flow From Operations | (260.02 M) | |||
| Earnings Per Share | (20.59) X | |||
| Total Asset | 460.23 M | |||
| Retained Earnings | (4.5 B) | |||
| Current Asset | 523.97 M | |||
| Current Liabilities | 40.37 M | |||
About Bluebird Bio Performance
By analyzing Bluebird Bio's fundamental ratios, stakeholders can gain valuable insights into Bluebird Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bluebird Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bluebird Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people.Things to note about Bluebird Bio performance evaluation
Checking the ongoing alerts about Bluebird Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bluebird Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bluebird Bio is not yet fully synchronised with the market data | |
| Bluebird Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.81 M. Net Loss for the year was (240.72 M) with profit before overhead, payroll, taxes, and interest of 28.19 M. | |
| Bluebird Bio currently holds about 132.51 M in cash with (260.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72. |
- Analyzing Bluebird Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bluebird Bio's stock is overvalued or undervalued compared to its peers.
- Examining Bluebird Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bluebird Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bluebird Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bluebird Bio's stock. These opinions can provide insight into Bluebird Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Bluebird Stock
If you are still planning to invest in Bluebird Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bluebird Bio's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |